Paul Maurin's experience includes French and international venture capital, private equity, M&A, and capital markets.
Paul regularly advises listed and unlisted companies and their managers at every stage of their development as well as their investors (venture capital and private equity firms, institutional and industrial investors). He represents issuers and investors in financing rounds, private and public M&A, LBOs, IPOs, private placements, and tender offers.
Paul's recent experience includes technology and life sciences companies (Stratumn, Voluntis, Nanobiotix). His recent investor-side representations include Partech Partners, Bpifrance, Creadev (Mulliez family), Piton Capital LLP, and Alven Capital Partners.
Examples of Paul's representations include the acquisitions by Ansys of Optis; the sale of A2Mac1 by its founders; the financing rounds of Doctolib, ManoMano, and Tinubu Square; the IPOs of Voluntis and Tikehau; the private placements of Nanobiotix and Cellnovo; and the share capital increase of Voltalia.
经验
- King's College London (LL.M. in International Financial Law with honors 2013); E.S.S.E.C. (Advanced Master in Management and International Business Law 2012); French Bar School of Paris (CAPA 2011); University of Aix Marseille (Advanced Master in International Business Law with honors 2008; D.J.C.E. [Diploma in Legal Practice] with honors 2008)
- Paris
- English, French
发送前请注意
*Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice